Age: 16.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chronic inflammatory demyelinating polyradiculoneuropathy, Immunoglobulin therapy, Lumbar puncture, Magnetic resonance imaging, Nerve conduction studies
Clinical narrative: can not walk or stand; polyneuritis; weakness; severe pain arms and legs; severe pain arms and legs; difficulty sleeping; difficulty swallowing; muscle pain (legs and arms); August 2021, First side effects in : sleep disturbance; fatigue; headache; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 16-year-old male patient received BNT162b2 (BNT162B2), on 27Aug2021 at 04:30 as dose 2, single (Lot number: EW0168) at the age of 16 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Cerebral palsy" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Amitriptyline, reaction(s): "Allergy"; Hydroxyzine hcl, reaction(s): "Allergy". Vaccination history included: BNT162b2 (Dose Number: 1, Batch/Lot No: EW0168, Location of injection: Arm Right, Vaccine Administration Time: 05:00 PM), administration date: 06Aug2021, when the patient was 16-year-old, for COVID-19 Immunization. The following information was reported: SLEEP DISORDER (hospitalization, disability) with onset Aug2021, outcome "not recovered", described as "August 2021, First side effects in : sleep disturbance"; FATIGUE (hospitalization, disability) with onset Aug2021, outcome "not recovered"; HEADACHE (hospitalization, disability) with onset Aug2021, outcome "not recovered"; MYALGIA (hospitalization, disability) with onset Sep2021, outcome "not recovered", described as "muscle pain (legs and arms)"; INSOMNIA (hospitalization, disability) with onset Oct2021, outcome "not recovered", described as "difficulty sleeping"; DYSPHAGIA (hospitalization, disability) with onset Oct2021, outcome "not recovered", described as "difficulty swallowing"; POLYNEUROPATHY (hospitalization, disability) with onset Oct2021, outcome "not recovered", described as "polyneuritis"; PAIN IN EXTREMITY (hospitalization, disability), PAIN IN EXTREMITY (hospitalization, disability) all with onset Oct2021, outcome "not recovered" and all described as "severe pain arms and legs"; ASTHENIA (hospitalization, disability) with onset Oct2021, outcome "not recovered", described as "weakness"; GAIT INABILITY (hospitalization, disability) with onset Nov2021, outcome "not recovered", described as "can not walk or stand". The patient was hospitalized for sleep disorder, fatigue, headache, myalgia, polyneuropathy, asthenia, pain in extremity, pain in extremity, insomnia, dysphagia, gait inability (hospitalization duration: 54 day(s)). The events "august 2021, first side effects in : sleep disturbance", "fatigue", "headache", "muscle pain (legs and arms)", "polyneuritis", "weakness", "severe pain arms and legs", "difficulty sleeping", "difficulty swallowing" and "can not walk or stand" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (29Oct2021) Positive, notes: Nasal Swab. Therapeutic measures were taken as a result of sleep disorder, fatigue, headache, myalgia, polyneuropathy, asthenia, pain in extremity, pain in extremity, insomnia, dysphagia, gait inability. AE treatment was IvIg. There was no covid prior vaccination. Covid was tested post vaccination.  No follow-up attempts are possible. No further information expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200828975 Same patient and drug, different event separated in time;